Talk about a busy day: we have Mr. Bernanke testifying, Treasury Secretary Geithner speaking, the Senate voting on the stimulus bill, and a huge Treasury auction at 1 PM.
Dow Chemical is seeing strong call activity despite a posting a weak earnings report yesterday. Early Thursday, traders bought some 10,700 calls at the February 12.40 strike, which quickly rose in price from $0.20 to $0.35. Many of those calls (DOWBV) were bought in blocks as large as 2,448 contracts each
As market participants anticipate possible stagnant growth in the coming quarters, investors might be more apt to get back to "old fashioned" investing with higher-yielding stocks.
Stocks ended higher Tuesday, snapping a three-day losing streak, as an earnings beat from Merck and better-than-expected housing report gave the market a boost.
Dividend-paying stocks, seen as a safer bet as the market worsens, are a trickier play as companies cut or eliminate dividends to shore up balance sheets.
Once again, a midday drop in the dollar has led to a (modest) rally in stocks. This happened yesterday. Traders are not stupid (they're just poor).
Stocks had a topsy-turvy morning as investors digested a revival in pending-home sales and an earnings beat from Merck against some gloomy news out of the tech sector.
Overseas markets are mixed this morning. Australia cut its interest rates to a record low 3.25 percent and unveiled a stimulus plan, while the Bank of Japan said it would buy up to $11 billion of shares held by banks.
US stock index futures struggled to find direction ahead of the open Tuesday, following a mixed close for stocks Monday, as investors feared the government stimulus plan may not provide the catalyst they hoped for.
Traders are watching tech as a bright spot in an otherwise tentative market, which is focused on a banking industry bailout, the economy and earnings news.
Cramer makes the call on viewers' favorite stocks.
It's amazing how much damage one man can do in such a short period of time.
Dow Chemical CEO Andrew Liveris still hopes his company can acquire specialty-chemical producer Rohm & Haas, despite some serious obstacles that have forced Dow to put the deal on hold.
That is the question this year about Davos. In such troubled economic times, expected participants—from Wall Street To Washington—are dropping like flies.
Warren Buffett sat down recently for a taped interview with Susie Gharib of Nightly Business Report to mark the PBS program's 30th anniverary tonight. In the conversation, Buffett hints Berkshire Hathaway might buy back some of its stock since it has fallen so sharply from its highs. He also says the credit crunch is easing but business conditions are getting worse. This is a transcript of that entire interview, as provided to us by NBR.
In November 2008, New York State Comptroller Thomas DiNapoli said that the financial crisis could lead to the loss of about 225,000 private sector positions in New York State over the next two years. The good news: many federal agencies are hiring.
Who among Bernie’s $50 billion worth of investors should get their money back? And what if some were in on the scam?
In Tuesday's Fast Money Pops & Drops post we mistakenly reported that Celgene stock dropped after the firm reported revenues on the low-end of projections...
Futures dropped about 5 points as the ADP said 693,000 private sector jobs were lost in December, much greater than the expected loss of 515,000. However, there was a change in methodology that was designed to close the gap between the ADP report and the nonfarm payroll report.
Following are the day’s biggest winners and losers. Find out why shares of Morgan Stanley and Dow Chemical popped while Reynolds American and Celgene dropped.